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In recent years several studies in the field of chronic
obstructive pulmonary disease (COPD) have addressed the
impact of comorbidities on the phenotypic presentation of
an individual patient [1]. Epidemiological studies have inves-
tigated the prevalence of comorbidities in COPD patients
and have reported clear associations between COPD and
other chronic diseases, such as cardiovascular, cancer, and
metabolic diseases as the most frequent ones. Since then the
awareness for coexisting diseases in COPD patients has been
steadily growing and their role on increasedmorbidity, worse
prognosis, and higher economic burden has currently been
recognized.
Notwithstanding, the clinical and pathophysiological
links between COPD and other chronic conditions remain
controversial and are largely unknown. Some authors suggest
that COPD may favor the development of other diseases
via the spilling of inflammatory mediators from the lung
to the systemic circulation. They indirectly support the idea
of a causal relationship between COPD and its comorbid
conditions. Others claim that the association of COPD and
coexisting diseases is only based on the presence of com-
mon risk factors [2], and there is also cumulating evidence
about activation of neurohumoral response [3]. In particular,
metabolic abnormalities and physical inactivity on top of
smoking may accumulate and intensify as COPD and its
coexisting diseases progress. From this point of view, the
term “multimorbidity” better reflects the concept of chronic
complex patients with COPD rather than that of COPD
patients with chronic comorbidities [4]. Moreover, advanta-
geous to the multimorbidity concept is that its recognition
in elderly adults also highlights the role of risk factors and
premorbid conditions in COPD as unexplored pathways
for intervention [5]. A comprehensive and individualized
approach is therefore warranted, and rehabilitation in its
broadest meaning may appear as best interventional process
to assess, care, and manage according to this holistic view
[6, 7].
The articles published within the special issue tackle
these concepts and review some important areas of both
assessing the presence of relevant coexisting conditions in
COPD, as well as evaluating the effect of comprehensive care
dedicated to these patients. In particular, the analysis of spe-
cific phenotypic clusters of these individuals, the presence of
specific conditions which may worsen prognosis and quality
of life, such as musculoskeletal disorders and dysfunction,
the cognitive impairment, and the cardiovascular problems
are reported. Moreover, the effectiveness of a rehabilitation
course and associated problems, in such complex patients, is
also reported in separate contributions.
In conclusion, actual evidence suggests that patients with
multimorbidity represent a huge part of the elderly popula-
tion, being COPD one component, not necessarily the most
important, of this clinical phenotype that requires a com-
prehensive assessment, care, and long-term management.
The respiratory community should recognize this complexity
of chronic care in patients with COPD, and health care
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providers should carefully consider all strategies of primary
and secondary prevention in the adult population.
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